If a company in Switzerland concludes that the use of a substance listed in Annex 1.17 Number 5 ORRChem is allowed because the European Commission has granted a company domiciled in the EU an approval for the same use of the substance, then the Swiss company must comply with the reporting requirement in accordance with Annex 1.17 Number 3.
Last modification 17.07.2019
